ARTICLE | Finance
June 17 Quick Takes: Trio of IPOs for Verve, Lyell and CARSgen; plus Biogen, Shoreline-Kite, Zhaoke-PanOptica and more
June 17, 2021 10:08 PM UTC
Despite waning enthusiasm for biotech IPOs, cardiovascular gene editing play Verve Therapeutics Inc. (NASDAQ:VERV) jumped $12.92 (68%) to $31.92 on its first day of trading Thursday after raising $266.7 million in a bumped-up IPO through the sale of 14 million shares at $19.
T cell reprogramming company Lyell Immunopharma Inc. (NASDAQ:LYEL) had a more lukewarm reception after raising $425 million through the sale of 25 million shares at $17, the midpoint of its proposed range. Lyell shed $0.11 to $16.89 on the day. ...